MET and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, hypomethylation of the LINE-1 (L1) retrotransposon promoter was reported to be more frequent in blast crisis, compared to chronic phase, and patients with hypomethylated L1 showed activation of MET transcription (Figure 4A) [129].